Articles tagged "Hypertension"

2021 American Transplant Congress
Recipient and Kidney Allograft Outcomes from Hypertensive Live-Donor in the United States
S. Riad¹, S. Jackson², D. Vock³, A. Matas⁴
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, M-Health Fairview, Minneapolis, MN, ³School of Public Health, University of Minnesota, Minneapolis, MN, ⁴Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Controlled hypertension in select prospective kidney donors is no longer an exclusion criterion for donation. We examined the association between pre-donation hypertension (HTN) and…
2021 American Transplant Congress
Portal Hypertension Abrogates Trail Expression of Liver Resident Nk Cells via Il-33
Y. Imaoka, M. Ohira, K. Sato, H. Ohdan
Hiroshima Uni., Hiroshima, Japan
*Purpose: Portal vein hypertension (PHT) is associated with poor prognosis, risk factors for small graft syndrome, bloodstream infection, and acute rejection after living donor liver…
2021 American Transplant Congress
Native Nephrectomy in Pediatric Kidney Transplant Recipients
D. Yoeli¹, A. Sater¹, A. Peace¹, M. E. Wachs¹, M. Bock², M. A. Adams¹
¹Transplant Surgery, Children’s Hospital Colorado, Aurora, CO, ²Pediatric Nephrology, Children’s Hospital Colorado, Aurora, CO
*Purpose: Data on native nephrectomy in children with renal disease requiring kidney transplantation is scarce. The aim of this study was to characterize demographics and…
2020 American Transplant Congress
Multi- National Survey among Nephrologists & Transplant Surgeons about the Suitability and Acceptance of the Marginal Live Kidney Donors with Mild Hypertension
Z. Arabi¹, E. Elhassan¹, A. Altheaby¹, A. Hamad², S. Kaysi³
¹KAMC, Riyadh, Saudi Arabia, ²The Regional Medical Center, Orangeburg, SC, ³CHR Orleans, Orleans, France
*Purpose: There is variability among transplant centers in the acceptance of living donor candidates with well-controlled hypertension. Increased gestational hypertension and preeclampsia are more common…
2020 American Transplant Congress
Cardiovascular Risk Factors in Patients after Liver Transplantion
M. Adamczak¹, D. Gojowy¹, J. Stompor¹, J. Adamusik¹, G. Smiech¹, H. Karkoszka¹, R. Krol², A. Wiecek¹
¹Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Katowice, Poland, ²Department of General, Vascular and Transplant Surgery, Medical University of Silesia, Katowice, Poland
*Purpose: The aim of this study was to estimate the prevalence of selected cardiovascular risk factors in patients after liver transplantation (LTx).*Methods: Medical records from…
2020 American Transplant Congress
Prevalence of Primary Aldosteronism in Kidney Transplant Recipients: A Cross-Sectional Study
N. Garg, C. D. Votruba, F. Aziz, S. Parajuli, M. Mohamed, A. Djamali, D. A. Mandelbrot
University of Wisconsin-Madison, Madison, WI
*Purpose: The prevalence of primary aldosteronism (PA) in the general hypertensive (HTN) population is more than 5%, and substantially higher at 20% in certain high-risk…
2020 American Transplant Congress
Cigarette Smoking and Long-Term Renal Function and Cardiovascular Disease in Living Kidney Donors
S. Getsin¹, M. Waldram¹, Y. Yu¹, D. Brennan¹, F. Al Ammary¹, J. Garonzik-Wang¹, M. Henderson¹, J. Locke², R. Reed², K. Lentine³, D. Segev¹, A. Massie¹
¹Johns Hopkins School of Medicine, Baltimore, MD, ²University of Alabama at Birmingham School of Medicine, Birmingham, AL, ³Saint Louis University School of Medicine, St. Louis, MO
*Purpose: Since cigarette smoking is a major risk factor for kidney and cardiovascular disease in the general population, many programs advise living kidney donor candidates…
2020 American Transplant Congress
Long-Term Outcomes in Recipients of Allografts from Living Kidney Donors with Hypertension
F. Al Ammary¹, S. Yu², A. Muzaale², L. Luckmini², D. C. Crews¹, D. Brennan¹, D. Segev², A. B. Massie²
¹Medicine, Johns Hopkins, Baltimore, MD, ²Surgery, Johns Hopkins, Baltimore, MD
*Purpose: Allografts from living kidney donors may “carry” subclinical pathological abnormalities to the recipient and thus lead to adverse clinical outcomes. Because one mechanism underlying…
2020 American Transplant Congress
Minor Negative Effects of Calcineurin Inhibitor Based Immunosuppression on Pregnancy Outcomes after Renal Transplantation in the Netherlands
L. M. Koenjer¹, J. R. Meinderts², A. T. Lely³, M. F. de Jong², O. W. van der Heijden¹, R. G. van der Molen⁴, H. W. van Hamersvelt⁵
¹Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, Netherlands, ²Nephrology, University Medical Center Groningen, Groningen, Netherlands, ³Obstetrics and Gynaecology, University Medical Center Utrecht, Utrecht, Netherlands, ⁴Immunology, Radboud University Medical Centre, Nijmegen, Netherlands, ⁵Nephrology, Radboud University Medical Centre, Nijmegen, Netherlands
*Purpose: Pregnancies after renal transplantation became more frequent over the past years, also in patients with compromised renal function. Immunosuppression may influence pregnancy outcome. It…
2020 American Transplant Congress
Impact on Graft Histology of Steroid Withdrawal versus Standard Immunosuppression: Randomized, Parallel Group, Controlled Clinical Trial in Low Immunological Risk Kidney Transplant Patients
E. Gutiérrez Vílchez¹, T. Vázquez¹, V. López¹, M. León², E. Sola¹, J. Sellares³, M. Cobo⁴, J. Cruzado⁵, A. Torío⁶, J. Kanter⁷, P. Ruiz-Esteban¹, D. Hernández¹
¹Nephrology Service, Regional University Hospital, University of Malaga, IBIMA, REDinREN (RD16/0009/0006), Málaga, Spain, ²Pathology Department, Regional University Hospital, University of Malaga, IBIMA, REDinREN (RD16/0009/0006), Málaga, Spain, ³Nephrology Department, Hospital Vall de Hebron, Barcelona, Spain, ⁴Cardiology Department, Hospital Marqués de Valdecilla, Santander, Spain, ⁵Nephrology Department, Hospital de Bellvitge, Barcelona, Spain, ⁶Immunology, Regional University Hospital, University of Malaga, IBIMA, REDinREN (RD16/0009/0006), Málaga, Spain, ⁷Nephrology Department, Hospital Universitario Dr. Peset, Valencia, Spain
*Purpose: Steroid withdrawal can improve cardiovascular risk but little is known about its impact on graft histology and donor-specific antibodies.*Methods: 105 patients with a first…